Your Roku has hidden settings and menu screens - here's how to unlock them ...

Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have designed a group of potential diabetes drugs that reprogram ...

Optimum announced Dec. 15 a new $40 million investment to expand its 100% fiber-to-the-home network across New Jersey. The latest follows nearly $200 million the company has invested in its Garden ...

Say adieu to the Altice USA name: The cable operator has changed its corporate name to Optimum Communications, effective immediately, to match its services brand identity. The company will cease ...

CANADA – 2025/10/27: In this photo illustration, the Altice logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images) Altice USA is ...

Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our immune system into protective T reg cells. These cells help ensure that the ...

The cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise and powerful than ever. From curing genetic diseases to designing the next ...

The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a preclinical model, scientists from the Institut Pasteur and Inserm ...

Cancer cells can brainwash their neighbors. Like the CIA deploying secret agents to turn an enemy, tumors use a similar strategy to manipulate nearby cells. The tumors’ agents are mitochondria, the ...

Across much of America, workers fear their options for remote work are slipping away. But remote work is alive and well, at least for now. Five years into the pandemic workplace revolution, roughly 38 ...

A first-in-class antisense oligonucleotide — RES-010 (Resalis Therapeutics, Turin, Italy) — may complement and enhance the efficacy of antiobesity drugs such as GLP-1 receptor agonists (RAs), ...